Social network-based recruitment successfully reveals HIV-1 transmission networks among high-risk individuals in El Salvador

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 1, 2013, Pages 135-141

  Dennis, Ann M ^a   Murillo, Wendy ^b   De Maria Hernandez, Flor ^c   Guardado, Maria Elena ^d   Nieto, Ana Isabel ^e   Lorenzana De Rivera, Ivette ^b   Eron, Joseph J ^a   Paz Bailey, Gabriela ^c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL AUTONOMOUS UNIVERSITY OF HONDURAS   (Honduras)

^c Valle University of Guatemala   (Guatemala)

^d Tephinet Inc   (United States)

^e Ministry of Health   (El Salvador)

Author keywords

El Salvador; HIV 1; molecular epidemiology; phylogenetic; respondentdriven sampling; transmission networks

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EL SALVADOR; GENE CLUSTER; GENE SEQUENCE; GENETIC DISTANCE; GEOGRAPHY; GONORRHEA; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MYCOPLASMA GENITALIUM; PHYLOGENY; PRIORITY JOURNAL; PROBABILITY; RESIDENTIAL AREA; SEXUAL BEHAVIOR; SOCIAL NETWORK; SYPHILIS; TRICHOMONIASIS; VIRUS GENE; VIRUS MUTATION;

EL SALVADOR; EPIDEMIOLOGIC METHODS; FEMALE; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; RISK; SAMPLING STUDIES; SEQUENCE ANALYSIS, DNA; SEX WORKERS; SOCIAL SUPPORT;

EID: 84876287809     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318288b246     Document Type: Article

References (31)

1. Chan M, Sidibe M, Lake A. Global HIV/AIDS response: epidemic update and health sector progress towards universal access-progress report 2011. Available at: http://www.who.int/hiv/pub/progress-report2011/en/. Accessed July 7, 2012.
2. Soto RJ, Ghee AE, Nunez CA, et al. Sentinel surveillance of sexually transmitted infections/HIV and risk behaviors in vulnerable populations in 5 Central American countries. J Acquir Immune Defic Syndr. 2007;46: 101-111.
3. Guardado ME, Criswell J, Monterroso E, et al. Encuesta Centroamer-icana de Vigilancia de Comportamiento Sexual y Prevalencia de VIH/ITS en Poblaciones Vulnerables, Hombres que Tienen Sexo con Hombres, Trabajadoras Sexuales y Personas con VIH, ECVC EL Salvador. San Salvador, El Salvador: Minisiterio de Salud de El Salvador, Universidad del Valle de Guatemala, USAID, CDC, PASMO; 2010.
4. Magnani R, Sabin K, Saidel T, et al. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(suppl 2): S67-S72.
5. Malekinejad M, Johnston LG, Kendall C, et al. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008;12(suppl): S105-S130.
6. Paz-Bailey G, Jacobson JO, Guardado ME, et al. How many men who have sex with men and female sex workers live in El Salvador? Using respondent-driven sampling and capture-recapture to estimate population sizes. Sex Transm Infect. 2011;87:279-282.
7. Lepej SZ, Vrakela IB, Poljak M, et al. Phylogenetic analysis of HIV sequences obtained in a respondent-driven sampling study of men who have sex with men. AIDS Res Hum Retroviruses. 2009;25:1335-1338.
8. Pilon R, Leonard L, Kim J, et al. Transmission patterns of HIV and hepatitis C virus among networks of people who inject drugs. PLoS One. 2011;6:e22245.
9. Hue S, Clewley JP, Cane PA, et al. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS. 2004;18:719-728.
10. Parekh BS, Kennedy MS, Dobbs T, et al. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses. 2002;18:295-307.
11. Dobbs T, Kennedy S, Pau CP, et al. Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol. 2004;42:2623-2628.
12. Parekh BS, Hanson DL, Hargrove J, et al. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses. 2011;27:265-273.
13. Lindstrom A, Albert J. A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1. J Virol Methods. 2003;107: 45-51.
14. Murillo W, de Rivera IL, Parham L, et al. Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment. HIV Med. 2010;11:95-103.
15. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947-2948.
16. Pond SLK, Posada D, Stawiski E, et al. An evolutionary model-based algorithm for accurate phylogenetic breakpoint mapping and subtype prediction in HIV-1. PLoS Comput Biol. 2009;5:e1000581.
17. Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007; 24:1596-1599.
18. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics. 2001;17:754-755.
19. Tracer v1.4 [computer program]. Available at: http://beast.bio.ed.ac.uk/- Tracer. Accessed April 14, 2011.
20. Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214.
21. Bennett D, Camacho R, Otelea D, et al. Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One. 2009;4:e4724.
22. McNutt L-A, Wu C, Xue X, et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003; 157:940-943.
23. Paintsil E, Verevochkin SV, Dukhovlinova E, et al. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction. 2009;104:1881-1890.
24. Caceres CF. HIV among gay and other men who have sex with men in Latin America and the Caribbean: a hidden epidemic? AIDS. 2002;16 (suppl 3):S23-S33.
25. Jacobson JO, Creswell J, Elena Guardado M, et al. Coverage of HIV prevention components among people with long-standing diagnosed HIV infection in El Salvador. Sex Transm Dis. 2012;39:694-700.
26. Ministerio de Salud Publica y Asistencia Social de El Salvador. Resumen de Casos de VIH-Sida: Notificacion en El Salvador. San Salvador, El Salvador: Ministerio de Salud; 2009: 1984-2008.
27. Vercauteren J, Wensing AMJ, van de Vijver DAMC, et al. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis. 2009;200: 1503-1508.
28. Poon AFY, Aldous JL, Mathews WC, et al. Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load. PLoS One. 2011;6: e21189.
29. Egger M, May M, Chene G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119.
30. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568-2577.
31. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.